On November 14, 2025, Chengdu Kanghua Biological Products Co Ltd announced that it has received a letter from Shanghai Wankexin Biotechnology Partnership, nominating Wang Li as a candidate for independent director of the Company's 3rd board of directors and proposing to submit this matter as a temporary proposal for review at the first extraordinary general meeting of shareholders scheduled to be held on November 25, 2025.